Carson Wealth (CWM LLC)
ADPT icon

Carson Wealth (CWM LLC)’s Adaptive Biotechnologies ADPT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Buy
26,084
+762
+3% +$12.1K ﹤0.01% 2256
2025
Q4 		$411K Sell
25,322
-4
-0% -$65 ﹤0.01% 2038
2025
Q3 		$379K Buy
25,326
+7,866
+45% +$95.8K ﹤0.01% 1954
2025
Q2 		$203K Sell
17,460
-1,487
-8% -$13.5K ﹤0.01% 2156
2025
Q1 		$141K Buy
18,947
+8,913
+89% +$68.5K ﹤0.01% 2146
2024
Q4 		$60K Buy
10,034
+715
+8% +$3.94K ﹤0.01% 2654
2024
Q3 		$48K Buy
9,319
+2,878
+45% +$12.5K ﹤0.01% 2714
2024
Q2 		$23K Buy
6,441
+2,796
+77% +$8.88K ﹤0.01% 3006
2024
Q1 		$12K Buy
3,645
+572
+19% +$2.21K ﹤0.01% 3209
2023
Q4 		$15K Sell
3,073
-2,658
-46% -$12.1K ﹤0.01% 2930
2023
Q3 		$31K Sell
5,731
-162,198
-97% -$1.07M ﹤0.01% 2376
2023
Q2 		$1.13M Sell
167,929
-7,022
-4% -$52.2K 0.01% 676
2023
Q1 		$1.54M Sell
174,951
-9,018
-5% -$79.5K 0.01% 532
2022
Q4 		$1.41M Sell
183,969
-38,701
-17% -$301K 0.01% 521
2022
Q3 		$1.58M Sell
222,670
-11,833
-5% -$111K 0.01% 449
2022
Q2 		$1.9M Sell
234,503
-34,676
-13% -$305K 0.01% 418
2022
Q1 		$3.74M Sell
269,179
-34,694
-11% -$545K 0.03% 333
2021
Q4 		$8.53M Buy
+303,873
New +$9.31M 0.06% 230
2021
Q2 		$4.25M Hold
103,941
– – 0.03% 299
2021
Q1 		$4.25M Hold
103,941
– – 0.03% 299
2020
Q4 		$4.25M Hold
103,941
– – 0.03% 299
2020
Q3 		$4.25M Hold
103,941
– – 0.03% 299
2020
Q2 		$4.25M Hold
103,941
– – 0.03% 299
2020
Q1 		$4.25M Hold
103,941
– – 0.03% 299
2019
Q4 		$4.25M Hold
103,941
– – 0.03% 299
2019
Q3 		$4.25M Hold
103,941
– – 0.03% 299
2019
Q2 		$4.25M Buy
+103,941
New +$4.6M 0.03% 299

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ADPT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Adaptive Biotechnologies (ADPT) stake by 3% in Q1 2026, buying an estimated $12.1K and bringing the position to 26,084 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Carson Wealth (CWM LLC) first reported a position in ADPT in Q2 2019 and has held it in 27 quarters since. The position peaked at $8.53M in Q4 2021. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 26,084 shares of Adaptive Biotechnologies worth $362K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 762 Adaptive Biotechnologies shares in Q1 2026, an estimated $12.1K.
  • Adaptive Biotechnologies made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2256 holding.
  • Carson Wealth (CWM LLC) first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 27 quarters since.
  • Carson Wealth (CWM LLC)'s Adaptive Biotechnologies position peaked at $8.53M in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.